Vincere Biosciences

About Vincere Biosciences

Vincere Biosciences is dedicated to developing new medicines to treat age-related diseases, such as Parkinson's and kidney disease, using innovative technologies to identify therapeutic targets.

Products & Services

Medicines for Age-Related Diseases:Developing new treatments targeting conditions like Parkinson's and kidney disease.

Virtual Cell Platform:A platform integrating human genetics, cellular network models, and in-silico biology to identify high-leverage therapeutic targets, with a focus on USP30 for mitochondrial repair.

Molecules for Clinical Trials:First molecule expected to reach human trials and potential pharma partnerships within 12 months, with additional molecules and indications in development.

Specialties

Age-Related Disease Treatment Parkinson's Disease Kidney Disease Virtual Cell Platform Human Genetics Cellular Network Models In-Silico Biology Mitochondrial Repair (USP30)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 5000000 MR: - FA: $5 million FAN: 5000000	D: 2025-11-18 FD: 2025-11-18	1 investors

Grant Latest

2025-11-18

$5.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Spring Behrouz

Chairman, & CEO

A

Andy D. Lee

Director, & CBO

J

James L. Liang

Director

D

Donna Romero

Development Lead

G

Greg Bisacchi

Medicinal Chemist

P

Peter Germano

DMPK Specialist

View 16 more team members with Pro

Unlock Full Team Directory

Recent News